Innovotech Inc. (TSXV: IOT; OTCQB: IOTCF), an Edmonton-based life sciences company specialising in applied microbiology and regulated laboratory services, has announced the launch of Streak Scientific, a new division supplying microbiology culture media, reagents, and laboratory consumables to Canadian laboratories. The division, operated under wholly owned subsidiary Innovotech Labs Corporation, began accepting online orders on November 10, 2026. The launch targets a Western Canadian market the company describes as historically underserved by domestic microbiology media suppliers, and is expected to diversify Innovotech's revenue base by adding recurring product sales alongside its existing laboratory testing services.

Key Points

  • Innovotech Inc. (TSXV: IOT; OTCQB: IOTCF) is an Edmonton-based life sciences services and technology company focused on applied microbiology and regulated laboratory services
  • The company launched Streak Scientific, a new division supplying culture media, agars, broths, prepared plates, and swabs to Canadian laboratories, with products priced in Canadian dollars and shipped from Edmonton
  • Online ordering launched November 10, 2026; product partners include international manufacturers HiMedia and Liofilchem
  • Investors may watch for updates on how the division contributes to recurring product revenue alongside Innovotech's core contract research and testing services

Streak Scientific Catalogue Targets Gap in Western Canadian Microbiology Supply

Streak Scientific's initial catalogue includes agars, dehydrated media, broths, fluid media, prepared plates, and swabs sourced from established international manufacturers including HiMedia and Liofilchem. All products are priced in Canadian dollars and shipped from Edmonton, eliminating the currency conversion and cross-border logistics that many Canadian laboratories have faced when sourcing from large foreign distributors. The release states that Western Canada has historically been underserved in this category, with laboratories often dependent on large distributors where personal service can be difficult to access. The company did not disclose specific revenue targets or catalogue size in the announcement.

Two Decades of In-House Microbiology Experience Underpins the New Division

Innovotech states it has used microbiology culture media products in its own GMP-accredited and ISO-certified laboratories for more than two decades, giving the company a practical, operational understanding of quality and consistency requirements. The company's GMP laboratory capabilities also allow Streak Scientific to assist customers with product qualification, including growth promotion testing, which the release suggests can reduce the internal validation burden for laboratories adopting new media. COO Jodi McDonald noted in the announcement that the division puts this accumulated experience, and the GMP laboratory's qualification capabilities, to work for laboratories across Canada.

Revenue Diversification Across Pharmaceutical, Healthcare, and Industrial Markets

Innovotech describes Streak Scientific as expected to generate a stable, recurring base of product sales that complements the company's existing laboratory testing services. The division makes use of Innovotech's existing laboratory infrastructure, quality systems, and established customer relationships, and is intended to strengthen engagement with clients in pharmaceutical, healthcare, food, academic, and industrial markets. The release states the company plans to broaden the product range over time in response to customer demand. The company did not disclose projected sales volumes, margins, or timelines for expanded catalogue additions in the announcement. The immediate share price impact was not clear from available public information.